From March 20th to 22nd, the PCHi 2024 China International Cosmetics, Personal and Home Care Raw Materials Exhibition was grandly opened at the Shanghai World Expo Exhibition & Convention Center. Enzyme Products made a stunning appearance with its star products, and the booth (1R52) was extremely popular, with a constant stream of customers coming to inquire!
1. Highlights
Enzyme Products showcased a variety of green ingredients, including star products such as S -Proxin, Ergothionein, Blue Copper Peptide, and Acetyl Carnosine, as well as the newly launched Green Carnosine .
The enzyme product was the first to achieve large-scale production using the carnosine enzyme method , and has been granted one invention patent and COSMOS APPROVED certification. The product has a purity of up to 99.9%, is free of hydrazine hydrate , and has stronger efficacy, higher safety, stability, and transdermal permeability compared to similar products
We have prepared trial packs of our full range of self-developed functional skincare products, as well as specially formulated products, to bring customers a unique exhibition experience.
2. Regarding finished enzyme products
Enzyme Products is committed to becoming a global leader in next-generation green active ingredients. Utilizing next-generation synthetic biology technology, the company focuses on the green production of active ingredients such as peptides, proteins, sugars, and nucleic acids. Leveraging over 20 years of research and industry experience accumulated by its founding team, the company has established a leading multidisciplinary technology platform in China. It has now achieved mass production of dozens of green active ingredients, including S- Proxine, copper peptide, ergothioneine, NMN, acetyl hexapeptide-8, and smegglutinin , providing high-quality green active ingredients to nearly a thousand well-known companies in the fields of functional skincare, biomedicine, and nutritional health.
After several years of rapid development, the company has achieved a leading position among domestic enterprises in terms of R&D investment, scale, and output. It has applied for more than 100 invention patents and has won more than ten national and local titles, including National Specialized and Innovative Small Giant, National High-tech Enterprise, Shenzhen Specialized and Innovative Small and Medium Enterprise, Shenzhen Potential Unicorn Enterprise, Shenzhen Postdoctoral Innovation Practice Base, Shenzhen Top 30 Medical and Health Innovation Team, Zhuhai Innovation and Entrepreneurship Team, and Gansu Specialized and Innovative Small and Medium Enterprise. In 2022, it was selected as one of Shenzhen’s Top 100 High-Growth Enterprises (first among unlisted biotech companies), and in 2023, it was selected as a Harvard Business Review High-Energy Innovation Team.